Motif Bio Invited to Present at Infectious Diseases Conference
Jun 22, 2017 06:00 am UTC| Business
NEW YORK, June 22, 2017 -- Motif Bio plc (NASDAQ:MTFB)(AIM:MTFB.LN), a clinical stage biopharmaceutical company specializing in developing novel antibiotics, today announced that Dr. David Huang, Chief Medical Officer...
SBM Offshore Awarded Turnkey and Lease and Operate Contracts for the ExxonMobil Liza FPSO
Jun 22, 2017 05:31 am UTC| Business
June 22, 2017 SBM Offshore is pleased to announce that ExxonMobil has formally confirmed the award of contracts for the next phase of the Liza project in Guyana. Under these contracts, SBM Offshore will construct,...
Jun 22, 2017 05:23 am UTC| Business
Liestal, Switzerland, June 22, 2017 - Santhera Pharmaceuticals (SIX: SANN) announces that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted Raxone (idebenone) a positive scientific opinion...
Diet Doc Adds Focus-Improving L-Theanine to its Prescription Line-Up
Jun 22, 2017 05:00 am UTC| Business
Charleston, WV, June 22, 2017 -- Medical weight loss program, Diet Doc is rolling out newly formulated prescriptions containing the amino acid, L-Theanine. L-Theanine is not common in the diet (it is only found in tea),...
Human Rights Advocates welcome new Executive Director of United for Human Rights Florida Chapter
Jun 22, 2017 04:37 am UTC| Business
CLEARWATER, Fla., June 22, 2017 -- On Wednesday, June 28th, United for Human Rights, a non-profit organization sponsored by the Church of Scientology, is hosting a reception for all human rights advocates to celebrate...
Income Inequality Is Strongly Linked to How Well Countries Convert Wealth into Well-Being
Jun 22, 2017 04:01 am UTC| Business
BOSTON, June 22, 2017 -- Countries with high levels of income inequality tend to have a weaker record at converting national wealth into well-being—and their people tend to be less happy than would be expected—than...
FibroGen Granted Orphan Drug Designation for Pamrevlumab in the Treatment of Pancreatic Cancer
Jun 22, 2017 02:10 am UTC| Business
SAN FRANCISCO, June 21, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation status to...